References
- Stella CL, Sibai BM. Preeclampsia: diagnosis and management of the atypical presentation. J Matern Fetal Neonatal Med 2006;19:381–6
- Wagner LK. Diagnosis and management of preeclampsia. Am Fam Physician 2004;70:2317–24
- Bhattacharya S, Campbell DM. The incidence of severe complications of preeclampsia. Hypertens Pregnancy 2005;24:181–90
- Statistisches Bundesamt (German Federal Statistical Office). Population movement: births and deaths; 2008. Available online at: http://www.destatis.de/jetspeed/portal/cms/Sites/destatis/Internet/EN/Content/Statistics/Bevoelkerung/GeburtenSterbefaelle/Tabellen/Content75/BirthDeaths,templateId=renderPrint.psml [last accessed August 2009]
- Deutsche Gesellschaft für Gynäkologie und Geburtshilfe (DGGG), Arbeitsgemeinschaft Schwangerschaftshochdruck/Gestose. AWMF. 2010. 015/018. Available online at: http://www.awmf.org/uploads/tx_szleitlinien/015-018_S1_Diagnostik_und_Therapie_hypertensiver_Schwangerschaftserkrankungen_05-2008_12-2011.pdf (accessed April 10 2013)
- Milne F, Redman C, Walker J, et al. The pre-eclampsia community guideline (PRECOG): how to screen for and detect onset of pre-eclampsia in the community. BMJ 2005;330:576–80
- Cnossen JS, ter Riet G, Mol BW, et al. Are tests for predicting pre-eclampsia good enough to make screening viable? A review of reviews and critical appraisal. Acta Obstet Gynecol Scand 2009;88:758–65
- Meads CA, Cnossen JS, Meher S, et al. Methods of prediction and prevention of pre-eclampsia: systematic reviews of accuracy and effectiveness literature with economic modelling. Health Technol Assess 2008;12:iii–iv, 1–270
- Buhimschi CS, Norwitz ER, Funai E, et al. Urinary angiogenic factors cluster hypertensive disorders and identify women with severe preeclampsia. Am J Obstet Gynecol 2005;192:734–41
- Muy-Rivera M, Vadachkoria S, Woelk GB, et al. Maternal plasma VEGF, sVEGF-R1, and PlGF concentrations in preeclamptic and normotensive pregnant Zimbabwean women. Physiol Res 2005;54:611–22
- Woolcock J, Hennessy A, Xu B, et al. Soluble Flt-1 as a diagnostic marker of pre-eclampsia. Aust N Z J Obstet Gynaecol 2008;48:64–70
- Robinson CJ, Johnson DD, Chang EY, et al. Evaluation of placenta growth factor and soluble Fms-like tyrosine kinase 1 receptor levels in mild and severe preeclampsia. Am J Obstet Gynecol 2006;195:255–9
- Lee ES, Oh MJ, Jung JW, et al. The levels of circulating vascular endothelial growth factor and soluble Flt-1 in pregnancies complicated by preeclampsia. J Korean Med Sci 2007;22:94–8
- Kim YJ, Park H, Lee HY, et al. Paraoxonase gene polymorphism, serum lipid, and oxidized low-density lipoprotein in preeclampsia. Eur J Obstet Gynecol Reprod Biol 2007;133:47–52
- Teixeira PG, Cabral AC, Andrade SP, et al. Placental growth factor (PlGF) is a surrogate marker in preeclamptic hypertension. Hypertens Pregnancy 2008;27:65–73
- Noori M, Donald AE, Angelakopoulou A, et al. Prospective study of placental angiogenic factors and maternal vascular function before and after preeclampsia and gestational hypertension. Circulation 2010;122:478–87
- Verlohren S, Galindo A, Schlembach D, et al. An automated method for the determination of the sFlt-1/PIGF ratio in the assessment of preeclampsia. Am J Obstet Gynecol 2010;202:161e161–161e111
- Hadker N, Garg S, Costanzo C, et al. Financial impact of a novel pre-eclampsia diagnostic test versus standard practice: a decision-analytic modeling analysis from a UK healthcare payer perspective. J Med Econ 2010;13:728–37
- Gebührenordnung für Ärzte (GOÄ) mit verkürzten Leistungsbezeichnungen (Fees for Doctors); 2008. Available online at: http://www.pkv.de/recht/rechtsquellen/gebuehrenordnung-fuer-aerzte-goae.pdf (accessed April 10 2013)
- National Online Pharmacy. Available online at: http://www.shop-apotheke.com/ [last accessed July 2009]
- Ausgaben der Krankenhäuser pro Pflegetag (Hospital Expenditures per Treatment Day). Published in Bundeszentrale für politische Bildung (BPD). Available online at: http://www.bpb.de/files/5L6A6B.pdf [last accessed July 2009]
- Statistisches Bundesamt (German Federal Statistical Office). Price and volume measures for hospital services in national accounts; 2008. Available online at: http://www.destatis.de/jetspeed/portal/cms/Sites/destatis/Internet/EN/Content/Publikationen/SpecializedPublications/Nationalaccounts/Pricehospitalservices,property=file.pdf [last accessed July 2009]
- Institut für das Entgeltsystem im Krankenhaus (InEK GmbH) (Institute for the Hospital Remuneration System). G-DRG-Fallpauschalen-Katalog 2009 nebst Anlagen (DRG Catalog 2009). Available online at: http://www.g-drg.de/cms/ (accessed April 10 2013)
- Lapaire O, Shennan A, Stepan H. The preeclampsia biomarkers soluble fms-like tyrosine kinase-1 and placental growth factor: current knowledge, clinical implications and future application. Eur J Obstet Gynecol Reprod Biol 2010;151:122–9
- Levine RJ, Maynard SE, Qian C, et al. Circulating angiogenic factors and the risk of preeclampsia. N Engl J Med 2004;350:672–83
- Bellamy L, Casas JP, Hingorani AD, Williams DJ. Pre-eclampsia and risk of cardiovascular disease and cancer in later life: systematic review and meta-analysis. BMJ 2007;335:974
- McDonald SD, Malinowski A, Zhou Q, et al. Cardiovascular sequelae of preeclampsia/eclampsia: a systematic review and meta-analyses. Am Heart J 2008;156:918–30
- Funai EF, Friedlander Y, Paltiel O, et al. Long-term mortality after preeclampsia. Epidemiology 2005;16:206–215
- Sibai BM. Caring for women with hypertension in pregnancy. JAMA 2007;298:1566–8